 |
市場調查報告書
商品編碼
1169185
癌症治療市場：按治療類型、癌症類型、最終用戶、地區 - 規模、份額、前景、機會分析，2022-2028 年Cancer Therapy Market, By Treatment Type, By Cancer Type, and By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 |
||||||
化學療法、放射療法、免疫療法和靶向療法等癌症治療可以幫助治愈、縮小或阻止癌症進展。 化療是一種使用藥物殺死癌細胞的治療方法。 一種藥物治療，使用強力化學物質殺死體內快速生長的細胞。 放射治療是一種使用高能輻射治療癌症的方法。 免疫療法是一種幫助免疫系統對抗癌症的癌症治療方法。 靶向治療是一種癌症治療，它針對癌細胞的變化以幫助它們生長、分裂和擴散。
市場動態
全球癌症患病率上升、對安全有效癌症治療的需求不斷增加、政府努力提高人們對癌症的認識以及大公司加大研發力度正在推動全球癌症治療市場。這些都是預計將推動癌症治療增長的主要因素
例如，根據印度醫學研究委員會 (ICMR) 的數據，印度患癌症的人數預計將從 2021 年的 2670 萬增加到 2025 年的 2980 萬。 因此，隨著癌症患病率的增加，對癌症治療的需求不斷增加，刺激了該地區全球癌症治療市場的增長。
此外，2022 年 3 月，美國食品和藥物管理局 (FDA) 批准了一種靶向並破壞癌細胞的新療法。 這種名為 177Lu-PSMA-617 的治療方法利用一種稱為 PSMA（前列腺特異性膜抗原）的分子，該分子選擇性地尋找並附著在癌細胞表面的特定蛋白質上。 該技術通過釋放破壞 DNA 的輻射來破壞癌細胞。
這項研究的主要特點
- 本報告對全球癌症治療市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2028 年）的市場規模和復合年增長率 (CAGR%) 增長情況。
- 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
- 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
- 根據以下參數對全球癌症治療市場的主要參與者進行了介紹，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
- 本研究涉及的主要公司包括輝瑞公司、諾華公司、默克公司、強生公司、葛蘭素史克公司、霍夫曼羅氏公司、拜耳公司、阿斯利康公司、安進公司和布裡斯托爾公司。邁爾斯施貴寶公司等。
- 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
- 《全球癌症治療藥物市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
- 利益相關者可以通過用於分析全球癌症治療市場的各種戰略矩陣來促進決策制定。
內容
第 1 章目的和先決條件
- 調查目的
- 先決條件
- 縮寫說明
第二章市場展望
- 報告內容
- 市場定義和範圍
- 執行摘要
- 市場概況：按治療類型分類
- 市場概況：按癌症類型
- 市場概況：按最終用戶分類
- 市場概況：按地區
- 連貫機會圖 (COM)
第 3 章市場動態、法規和趨勢分析
- 市場動態
- 全球癌症發病率上升
- 癌症治療費用高昂
- 對安全有效的癌症治療的需求不斷增長
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/批准
- 害蟲分析
- 對 PORTER 的分析
- 合併/收購場景
第 4 章全球癌症治療市場 - 冠狀病毒 (COVID-19) 大流行的影響
- COVID-19 的流行病學特徵
- 供應方和需求方分析
- 經濟影響
第 5 章全球癌症治療市場，按治療類型，2017-2028
- 化療
- 靶向治療
- 免疫療法
- 激素療法
- 其他
第 6 章。全球癌症治療市場，按癌症類型，2017-2028
- 血癌
- 乳腺癌
- 前列腺癌
- 皮膚癌
- 肺癌
- 其他
第 7 章。全球癌症治療市場，按最終用戶分類，2017-2028
- 醫院
- 專科診所
- 放射中心
第 8 章全球癌症治療市場，按地區劃分，2017-2028
- 北美
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東和非洲
- 世界其他地方
第9章競爭格局
- Pfizer Inc.
- Novartis AG
- Merck & Co. Inc.
- Johnson & Johnson
- GlaxoSmithKline PLC
- Hoffmann-La Roche Ltd.
- Bayer AG
- AstraZeneca
- Amgen
- Bristol-Myers Squibb Company
第 10 章
- 調查方法介紹
- 關於出版商
Cancer therapies, such as chemotherapy, radiation therapy, immunotherapy, and targeted therapy, help cure a cancer, shrink a cancer, or stop the progression of a cancer. Chemotherapy uses drugs to kill cancer cells. It is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. Radiation therapy is the use of high-energy radiation to treat cancer. An immunotherapy is a type of cancer treatment that helps the immune system fight cancer. Targeted therapy is a type of cancer treatment that targets the changes in cancer cells that help them grow, divide, and spread.
Market Dynamics:
Rising prevalence of cancer worldwide, increase in demand for safe and effective cancer therapy, government initiatives for cancer awareness, and increase in research and development initiatives by key players are major factors expected to drive growth of the global cancer therapy market.
For instance, according to the Indian Council for Medical Research (ICMR), the number of Indians suffering from cancer is expected to rise to 29.8 million in 2025 from 26.7 million in 2021. Thus, with the increase in prevalence of cancer, the demand for cancer therapy, diving the growth of the global cancer therapy market in the region.
Moreover, in March 2022, the U.S. Food and Drug Administration (FDA) approved a new therapy that zeros in on cancer cells to destroy them. The treatment, 177Lu-PSMA-617, uses a molecule that selectively seeks out and attaches to a specific protein on the cancer cell surface called PSMA (prostate-specific membrane antigen). The technology delivers radiation that damages DNA and destroys the cancer cell.
Key features of the study:
- This report provides in-depth analysis of the global cancer therapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cancer therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline PLC, Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca, Amgen, and Bristol-Myers Squibb Company, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cancer therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer therapy market.
Detailed Segmentation:
- Global Cancer Therapy Market, By Treatment Type:
- Chemotherapy
- Target Therapy
- Immunotherapy Therapy
- Hormone Therapy
- Others
- Global Cancer Therapy Market, By Cancer Type:
- Blood Cancer
- Breast Cancer
- Prostate cancer
- Skin Cancer
- Lung Cancer
- Others
- Global Cancer Therapy Market, By End User:
- Hospital
- Specialty Clinic
- Radiation Center
- Global Cancer Therapy Market, By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
- Company Profiles:
- Pfizer Inc.
- Novartis AG
- Merck & Co. Inc.
- Johnson & Johnson
- GlaxoSmithKline PLC
- Hoffmann-La Roche Ltd.
- Bayer AG
- AstraZeneca
- Amgen
- Bristol-Myers Squibb Company
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapsahot, By Cancer Type
- Market Snapshot, By End Users
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in prevalence of cancer around the world
- High cost of cancer treatment/therapy
- Increase in demand for safe and effective cancer therapy
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Cancer Therapy Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Cancer Therapy Market, By Treatment Type, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Target Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Immunotherapy Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
6. Global Cancer Therapy Market, By Cancer Type, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Prostate cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Skin Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
7. Global Cancer Therapy Market, By End Users, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Specialty Clinic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
- Radiation Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
8. Global Cancer Therapy Market, By Geography, 2017-2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
- Rest of World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
9. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co. Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
